Neumora Therapeutics (NMRA) Change in Accured Expenses (2022 - 2026)
Neumora Therapeutics' Change in Accured Expenses was -$1.44 million in Q2 2026, compared with -$6.33 million a year earlier.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Change in Accured Expenses (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neumora Therapeutics' Change in Accured Expenses was $3.39 million through Jun 30, 2026, down 28.8% year-over-year; for FY2025, it came in at $4.2 million, down 42.0% from FY2024.
- In earlier years, Change in Accured Expenses was $7.24 million in FY2024 (+11.6%), $6.49 million in FY2023 and -$1.62 million in FY2022.
- Quarterly Change in Accured Expenses has moved between -$6.33 million (Q2 2025) and $7.58 million (Q3 2024) over five years.
- Per Business Quant data, NMRA's Change in Accured Expenses in the three quarters before Q2 2026 was -$4.02 million (Q1 2026), $3.98 million (Q4 2025) and $4.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -251.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 901.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 338.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 222.50 Mn |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - | -1.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.44 Mn |
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | -6.33 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | -4.11 Mn |
| Dec 31, 2023 | -2.16 Mn |
| Sep 30, 2023 | 6.26 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | -736,000.00 |
| Dec 31, 2022 | 7.03 Mn |
API Access
Neumora Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();